v3.19.3.a.u2
Consolidated statement of changes in equity/(deficit) - EUR (€)
€ in Millions
Total
Number of Ordinary Shares Outstanding
Share Capital
Treasury Shares
Other Paid in Capital
Other Reserves
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2016   149,924,000          
Beginning balance at Dec. 31, 2016 € (240)   € 0   € 830 € 122 € (1,192)
Loss for the year (1,235)   0   0 0 (1,235)
Other comprehensive income (loss) (15)   0   0 (15) 0
Issuance of shares upon exercise of stock options and restricted stock units 29   0   29 0 0
Issuance of shares upon exercise of stock options and restricted stock units, shares   1,723,080          
Issuance of share-based payments in conjunction with business combinations 0            
Restricted stock units withheld for employee taxes 0            
Issuance of shares related to business combinations 33   0   33 0 0
Issuance of shares related to business, shares   442,040          
Issuance of restricted share awards related to business combination 0   0   0 0 0
Issuance of restricted share awards related to business combination, shares   61,880          
Issuance of shares upon exchange of Convertible Notes 686   0   686 0 0
Issuance of shares upon exchange of Convertible Notes, shares   6,554,960          
Issuance of shares in exchange for long term investment 910   0   910 0 0
Issuance of shares in exchange for long term investment, shares   8,552,440          
Share-based payments 67   0   0 67 0
Income tax impact associated with share-based payments 3         3  
Ending balance at Dec. 31, 2017 238   0   2,488 177 (2,427)
Ending balance (in shares) at Dec. 31, 2017   167,258,400          
Loss for the year (78)   0   0 0 (78)
Other comprehensive income (loss) 564         564  
Issuance of ordinary shares 4       4    
Issuance of ordinary shares, shares   5,776,920          
Repurchases of ordinary shares € (77)     € (77)      
Repurchases of ordinary shares, Shares (6,427,271) (6,427,271)          
Issuance of shares upon exercise of stock options and restricted stock units € 163   0   163 0 0
Issuance of shares upon exercise of stock options and restricted stock units, shares   4,816,072          
Issuance of share-based payments in conjunction with business combinations 0            
Restricted stock units withheld for employee taxes (2)         (2)  
Issuance of shares upon exchange of Convertible Notes 1,146   0   1,146 0 0
Issuance of shares upon exchange of Convertible Notes, shares   9,431,960          
Share-based payments 88   0   0 88 0
Income tax impact associated with share-based payments 48   0   0 48 0
Ending balance (Previously stated) at Dec. 31, 2018 2,094     (77) 3,801 875 (2,505)
Ending balance (Cumulative effect adjustment in connection with the adoption of IFRS 16) at Dec. 31, 2018 (18)           (18)
Ending balance (After adoption of IFRS 16) at Dec. 31, 2018 2,076     (77) 3,801 875 (2,523)
Ending balance at Dec. 31, 2018 2,094            
Ending balance (in shares) (Previously stated) at Dec. 31, 2018   180,856,081          
Ending balance (in shares) (After adoption of IFRS 16) at Dec. 31, 2018   180,856,081          
Loss for the year (186)   0   0 0 (186)
Other comprehensive income (loss) (111)   0   0 (111) 0
Repurchases of ordinary shares € (433)     (433)      
Repurchases of ordinary shares, Shares (3,679,156) (3,679,156)          
Issuance of shares upon exercise of stock options and restricted stock units € 154   0 140 14 0 0
Issuance of shares upon exercise of stock options and restricted stock units, shares   3,557,405          
Issuance of shares upon exercise of, or net settlement of, warrants 377       377    
Issuance of shares upon exercise of, or net settlement of warrants, shares   3,591,627          
Issuance of share-based payments in conjunction with business combinations 13         13  
Restricted stock units withheld for employee taxes (6)         (6)  
Share-based payments 127   0   0 127 0
Income tax impact associated with share-based payments 26   0   0 26 0
Ending balance at Dec. 31, 2019 € 2,037   € 0 € (370) € 4,192 € 924 € (2,709)
Ending balance (in shares) at Dec. 31, 2019   184,325,957